BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30558824)

  • 21. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
    Bustillo JR; Chen H; Gasparovic C; Mullins P; Caprihan A; Qualls C; Apfeldorf W; Lauriello J; Posse S
    Biol Psychiatry; 2011 Jan; 69(1):19-27. PubMed ID: 20970118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal
    Cai XL; Pu CC; Zhou SZ; Wang Y; Huang J; Lui SSY; Møller A; Cheung EFC; Madsen KH; Xue R; Yu X; Chan RCK
    Psychol Med; 2023 Aug; 53(11):4904-4914. PubMed ID: 35791929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Anterior Cingulate Cortex Neurochemical Profile and Clinical Remission After Electroconvulsive Treatment in Major Depressive Disorder: A Longitudinal 1H Magnetic Resonance Spectroscopy Study.
    Ermis C; Aydin B; Kucukguclu S; Yurt A; Renshaw PF; Yildiz A
    J ECT; 2021 Dec; 37(4):263-269. PubMed ID: 33840802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of spectral basis set composition on estimated levels of cingulate glutamate and its associations with different personality traits.
    Demler VF; Sterner EF; Wilson M; Zimmer C; Knolle F
    BMC Psychiatry; 2024 Apr; 24(1):320. PubMed ID: 38664663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls.
    Arumuham A; Nour MM; Veronese M; Beck K; Onwordi EC; Lythgoe DJ; Jauhar S; Rabiner EA; Howes OD
    Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38373256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate-A pilot study.
    Jelen LA; Green MS; King S; Morris AG; Zhang X; Lythgoe DJ; Young AH; De Belleroche J; Stone JM
    Front Psychiatry; 2022; 13():929306. PubMed ID: 36203844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder.
    Singh M; Spielman D; Adleman N; Alegria D; Howe M; Reiss A; Chang K
    Psychiatry Res; 2010 May; 182(2):165-71. PubMed ID: 20413280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABA, glutamatergic dynamics and BOLD contrast assessed concurrently using functional MRS during a cognitive task.
    Craven AR; Dwyer G; Ersland L; Kazimierczak K; Noeske R; Sandøy LB; Johnsen E; Hugdahl K
    NMR Biomed; 2024 Mar; 37(3):e5065. PubMed ID: 37897259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
    Bryll A; Krzyściak W; Karcz P; Śmierciak N; Kozicz T; Skrzypek J; Szwajca M; Pilecki M; Popiela TJ
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between increased anterior cingulate glutamate and psychotic-like experiences, but not autistic traits in healthy volunteers.
    Demler VF; Sterner EF; Wilson M; Zimmer C; Knolle F
    Sci Rep; 2023 Aug; 13(1):12792. PubMed ID: 37550354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic underpinnings of activated and deactivated cortical areas in human brain.
    Koush Y; de Graaf RA; Kupers R; Dricot L; Ptito M; Behar KL; Rothman DL; Hyder F
    J Cereb Blood Flow Metab; 2021 May; 41(5):986-1000. PubMed ID: 33472521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoupling of Brain Temperature and Glutamate in Recent Onset of Schizophrenia: A 7T Proton Magnetic Resonance Spectroscopy Study.
    Posporelis S; Coughlin JM; Marsman A; Pradhan S; Tanaka T; Wang H; Varvaris M; Ward R; Higgs C; Edwards JA; Ford CN; Kim PK; Lloyd AM; Edden RAE; Schretlen DJ; Cascella NG; Barker PB; Sawa A
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Mar; 3(3):248-254. PubMed ID: 29486866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
    Lopes JJ; Carruthers SP; Meyer D; Dean B; Rossell SL
    Aust N Z J Psychiatry; 2024 May; ():48674241254216. PubMed ID: 38812258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in steady-state glutamate levels and variability between 'non-task-active' conditions: Evidence from
    Lynn J; Woodcock EA; Anand C; Khatib D; Stanley JA
    Neuroimage; 2018 May; 172():554-561. PubMed ID: 29421322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Working Memory Modulates Glutamate Levels in the Dorsolateral Prefrontal Cortex during
    Woodcock EA; Anand C; Khatib D; Diwadkar VA; Stanley JA
    Front Psychiatry; 2018; 9():66. PubMed ID: 29559930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resting state and activated brain glutamate-glutamine, brain lactate, cognition, and psychopathology among males with schizophrenia: A 3 Tesla proton magnetic resonance spectroscopic (1H-MRS) study.
    Singh U; Das B; Khanra S; Roy C
    Indian J Psychiatry; 2024 Jan; 66(1):82-89. PubMed ID: 38419937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia.
    Griffiths K; Smart SE; Barker GJ; Deakin B; Lawrie SM; Lewis S; Lythgoe DJ; Pardiñas AF; Singh K; Semple S; Walters JTR; Williams SR; Egerton A; MacCabe JH
    Schizophr Res; 2023 Oct; 260():152-159. PubMed ID: 37657282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.
    Bryant JE; Frölich M; Tran S; Reid MA; Lahti AC; Kraguljac NV
    J Psychiatr Res; 2019 Oct; 117():108-115. PubMed ID: 31376621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders.
    Chiappelli J; Savransky A; Ma Y; Gao S; Kvarta MD; Kochunov P; Slavich GM; Hong LE
    Schizophr Res; 2024 Jul; 269():58-63. PubMed ID: 38733800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.
    Dogan AE; Yuksel C; Du F; Chouinard VA; Öngür D
    Neuropsychopharmacology; 2018 Jul; 43(8):1681-1690. PubMed ID: 29581538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.